Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
Crossref DOI link: https://doi.org/10.1007/s12325-017-0538-3
Published Online: 2017-04-26
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gulácsi, László
Brodszky, Valentin
Baji, Petra
Rencz, Fanni
Péntek, Márta
Text and Data Mining valid from 2017-04-26
Article History
First Online: 26 April 2017